Protective effects of Angelica keiskei extract against TNF-α-induced oxidative stress and vascular inflammation in human umbilical vein endothelial cells
Open Access
- 31 August 2024
- journal article
- Published by The Korean Society of Food Preservation in Food Science and Preservation
- Vol. 31 (4) , 590-600
Abstract
Angelica keiskei, a perennial herb from Apiaceae family, has been reported to improve diabetes, inhibit thrombosis, alleviate dyslipidemia, and prevent type 2 diabetes, obesity, and atherosclerosis. In this study, the protective effects of A. keiskei extract (AKE) against tumor necrosis factor-alpha (TNF-α)-induced oxidative stress and vascular inflammation in human umbilical vein endothelial cells (HUVECs) were investigated through cell viability analysis, antioxidant enzyme analysis, western blotting, and immunofluorescence staining. The results demonstrated that pretreatment of Angelica keiskei with AKE significantly inhibited the expression of key adhesion molecules such as E-selectin, ICAM-1 and VCAM-1 induced by TNF-α. AKE also showed a substantial reduction in intracellular reactive oxygen species levels and an increase in antioxidant enzyme activity, indicating potential antioxidant capabilities. This study further explained that AKE interfered with the nuclear factor-kappa B (NF-κB) pathway by inhibiting phosphorylation of IκBα and NF-κB, thereby preventing nuclear translocation. Additionally, AKE selectively inhibited the activation of c-Jun N-terminal kinase (JNK) within the mitogen-activated protein kinase (MAPK) pathway, revealing a specific action mechanism. These findings collectively suggest that AKE possesses multi-faceted protective properties, making it a potential therapeutic agent for inflammatory conditions and early atherosclerosis.Keywords
Funding Information
- Ministry of SMEs and Startups
This publication has 35 references indexed in Scilit:
- Analysis of plasma metabolic profiling and evaluation of the effect of the intake of Angelica keiskei using metabolomics and lipidomicsJournal of Ethnopharmacology, 2019
- Angelica keiskei, an emerging medicinal herb with various bioactive constituents and biological activitiesArchives of Pharmacal Research, 2017
- Potent anti-inflammatory effect of dioscin mediated by suppression of TNF-α-induced VCAM-1, ICAM-1and EL expression via the NF-κB pathwayBiochimie, 2015
- Vascular oxidative stress, nitric oxide and atherosclerosisAtherosclerosis, 2014
- Apelin–APJ induces ICAM-1, VCAM-1 and MCP-1 expression via NF-κB/JNK signal pathway in human umbilical vein endothelial cellsAmino Acids, 2012
- TNFR1-induced NF-κB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cellsCellular Signalling, 2007
- Pathogenesis of AtherosclerosisJACC, 2006
- Nuclear factor κB: a potential therapeutic target in atherosclerosis and thrombosisCardiovascular Research, 2004
- Inhibition of TNF-α induced ICAM-1, VCAM-1 and E-selectin expression by seleniumAtherosclerosis, 2002
- AtherosclerosisCell, 2001